Insurance and Medicare
What gets covered depends on the use, the plan, and the fine print
Insurance may pay for a medicine when it treats one illness and refuse to pay when it is used for another.
Medicare
The reason for the prescription changes the answer
Federal law, as of September 2026, still let Medicare drug plans (Part D) refuse to pay for a medicine when the purpose is weight loss.
That same medicine, as of September 2026, could qualify for Part D coverage when prescribed for another reason, such as type 2 diabetes or lowering the risk of heart attack and stroke.
Qualifying is not the same as being paid for. Each plan keeps its own list of the drugs it pays for, and it may require your doctor to get the plan’s approval before it pays. That step is called prior authorization.
A temporary Medicare program
A short-term program with its own rules
GLP-1 medicines are the weight-loss and diabetes medicines sold as Ozempic, Wegovy, Mounjaro, and Zepbound.
For some of these, Medicare had a temporary program in place as of September 2026, the GLP-1 Bridge, running July 1, 2026, to December 31, 2027.
People with Medicare drug coverage who qualified paid $50 for a month’s supply of certain of these medicines.
That $50 did not count toward the deductible, the amount you pay each year before your plan starts paying, or toward your annual out-of-pocket maximum.
Coupons could not be added on top.
Not everyone with Medicare qualified: the program ran separately from the usual drug plan, and it had to approve each person before it paid.
To find out whether you qualify, use the Medicare pages linked here or ask Medicare directly.
Other plans
With private insurance, call your own plan
Ask your insurer about the exact medicine and the exact reason it was prescribed. Then ask: How much do I pay before coverage starts? Does my doctor need the plan’s approval first? Must I try a cheaper medicine first (called step therapy)? Is there a limit on how much I can get each month? Which pharmacy must I use?
As of September 2026, you needed private insurance, for example a job-based plan, to use the makers’ savings cards for Ozempic, Wegovy, Mounjaro, and Zepbound.
They excluded Medicare, Medicaid, and military coverage.
A drug maker’s cash price for people paying on their own is a different offer from a savings card. Do not mix the two up.